Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Public Statement |
Series Details | EMA/763463/2009 (16.4.10) |
Publication Date | 16/04/2010 |
Content Type | News |
The European Medicines Agency (EMA) and its Committee for Advanced Therapies issued a public statement on 16 April 2010, urging that access to medicinal products containing stem cells should only be under certain controlled conditions. |
|
Source Link | Link to Main Source http://www.ema.europa.eu/pdfs/human/cat/76346309en.pdf |
Subject Categories | Business and Industry, Health |
Countries / Regions | Europe |